Literature DB >> 18647986

Heart failure with preserved ejection fraction: treat now by treating comorbidities.

Sanjiv J Shah1, Mihai Gheorghiade.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18647986     DOI： 10.1001/jama.300.4.431

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  64 in total

1.  Heart failure with a normal ejection fraction: treatments for a complex syndrome?

Authors:  Samuel Bernard; Mathew S Maurer
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-08

2.  In-hospital management of heart failure: in 10 years we have improved, but not enough.

Authors:  Sonia Ferretto; Chiara Dalla Valle; Sonia Cukon Buttignoni; Luca Brugnaro; Giovanni Maria Boffa
Journal:  Intern Emerg Med       Date:  2010-12-09       Impact factor: 3.397

3.  Stopping the cardiovascular disease continuum: Focus on prevention.

Authors:  Steven G Chrysant
Journal:  World J Cardiol       Date:  2010-03-26

4.  A systematic assessment of causes of death after heart failure onset in the community: impact of age at death, time period, and left ventricular systolic dysfunction.

Authors:  Douglas S Lee; Philimon Gona; Irene Albano; Martin G Larson; Emelia J Benjamin; Daniel Levy; William B Kannel; Ramachandran S Vasan
Journal:  Circ Heart Fail       Date:  2010-11-11       Impact factor: 8.790

5.  Untargeted metabolomic analysis of coronary artery disease patients with diastolic dysfunction show disturbed oxidative pathway.

Authors:  Tamkeen Fatima; Satwat Hashmi; Ayesha Iqbal; Amna Jabbar Siddiqui; Shahid A Sami; Najeeb Basir; Syeda Saira Bokhari; Hasanat Sharif; Syed Ghulam Musharraf
Journal:  Metabolomics       Date:  2019-06-24       Impact factor: 4.290

6.  Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community.

Authors:  Carolyn S P Lam; Asya Lyass; Elisabeth Kraigher-Krainer; Joseph M Massaro; Douglas S Lee; Jennifer E Ho; Daniel Levy; Margaret M Redfield; Burkert M Pieske; Emelia J Benjamin; Ramachandran S Vasan
Journal:  Circulation       Date:  2011-06-13       Impact factor: 29.690

Review 7.  How to Develop and Implement a Specialized Heart Failure with Preserved Ejection Fraction Clinical Program.

Authors:  Sanjiv J Shah; Rebecca Cogswell; John J Ryan; Kavita Sharma
Journal:  Curr Cardiol Rep       Date:  2016-12       Impact factor: 2.931

8.  Treating anemia in older adults with heart failure with a preserved ejection fraction with epoetin alfa: single-blind randomized clinical trial of safety and efficacy.

Authors:  Mathew S Maurer; Sergio Teruya; Bibhas Chakraborty; Stephen Helmke; Donna Mancini
Journal:  Circ Heart Fail       Date:  2012-12-20       Impact factor: 8.790

9.  Baseline characteristics of patients in the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial.

Authors:  Sanjiv J Shah; John F Heitner; Nancy K Sweitzer; Inder S Anand; Hae-Young Kim; Brian Harty; Robin Boineau; Nadine Clausell; Akshay S Desai; Rafael Diaz; Jerome L Fleg; Ivan Gordeev; Eldrin F Lewis; Valetin Markov; Eileen O'Meara; Bondo Kobulia; Tamaz Shaburishvili; Scott D Solomon; Bertram Pitt; Marc A Pfeffer; Rebecca Li
Journal:  Circ Heart Fail       Date:  2012-12-20       Impact factor: 8.790

10.  Novel strategies for the detection of systolic and diastolic heart failure.

Authors:  Cara Lodewijks-Vd Bolt; Leo Baur; Jelle Stoffers; Timo Lenderink; Ron Winkens
Journal:  Curr Cardiol Rev       Date:  2009-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.